GeneDx Holdings WGS Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$63.32M-870% | -$17.67M— | -$7.64M+8.1% | $10.81M+137% | -$6.53M+67.7% | ||
| $6.81M+19.9% | $6.88M+23.8% | $6.47M+9.2% | $6.19M+18.6% | $5.68M+8.2% | ||
| $9M+126% | $9.78M+244% | $10.59M+191% | $7.81M+151% | $3.98M+983% | ||
| $897K+101% | —— | $246K+623% | —— | $447K+645% | ||
| $31.29M— | —— | —— | —— | $0— | ||
| $2.56M-70.1% | $13.43M— | $12.91M+3.5% | $1.33M+155% | $8.56M+303% | ||
| -$1.69M-183% | $3.36M+641% | —— | —— | $2.03M-29.4% | ||
| -$13.17M-222% | $6.92M+154% | —— | —— | $10.82M+329% | ||
| $1.03M+36.6% | $781K+20.5% | $995K+10.4% | $630K-26.1% | $757K-14.6% | ||
| -$6.57M— | —— | —— | —— | $0— | ||
| -$32.41M-418% | $0+100% | $15.77M+459% | $10.42M+331% | $10.18M+162% | ||
| $6.45M+5.3% | $4.35M+42.5% | $6.17M+855% | $2.37M+75.2% | $6.13M+1,284% | ||
| $875K— | $2.06M+68,633% | $0— | $0— | $0-100% | ||
| -$17.26M-83.4% | -$11.07M-2,033% | -$4.69M+39.6% | -$36.35M-60.1% | -$9.41M-1,216% | ||
| —— | —— | —— | —— | —— | ||
| $476K— | $1.04M+607% | $182K+112% | $800K+484% | $0-100% | ||
| $495K-19.0% | $377K-69.3% | $912K+79.2% | $551K+4.4% | $611K+32.3% | ||
| $38.59M+181% | $23.19M-25.2% | $10.77M-22.9% | $346K+188% | $13.72M+3,232% | ||
| -$11.07M-176% | $9.03M— | $21.85M— | -$25.58M+7.3% | $14.49M+191% | ||
| $1.75M+9.3% | $1.58M-3.9% | $1.63M+62.2% | $1.61M-20.1% | $1.6M-20.8% | ||
| $754K+266% | $236K-8.2% | $119K-66.3% | $714K+178% | $206K-31.3% | ||
| $31.29M— | —— | —— | —— | $0— | ||
| -$1.02M+26.7% | —— | -$3.73M— | -$3.62M-187% | -$1.4M-823% | ||
| $8.5M-39.0% | $10.02M-37.8% | $7.25M-55.3% | $12.78M+346% | $13.93M+138% | ||
| $875K— | $2.06M+68,633% | $0— | $0— | $0-100% | ||
| $495K-19.0% | $377K-69.3% | $912K+79.2% | $551K+4.4% | $611K+32.3% | ||
| $97M+598% | $21.14M-33.8% | $11.8M-19.1% | $0— | $13.89M— | ||
| $5.92M+169% | $1.81M— | —— | $3.56M+665% | $2.2M+6,003% | ||
| -$2.54M-331% | —— | $3.4M+286% | -$2.18M-149% | $1.1M-82.0% | ||
| $12.09M— | —— | —— | —— | $0— | ||
| —— | $0— | $0— | $0— | $0— | ||
| -$38.86M-1,059% | —— | $9.6M+290% | $8.05M+237% | $4.05M+124% | ||
| -$38.86M-1,059% | —— | $9.6M+290% | $8.05M+237% | $4.05M+124% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does GeneDx Holdings's cash flow data come from?
- Every line is extracted from GeneDx Holdings's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.